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ABSTRACT 
The use of Propionibacrerium acnes as an immunostimulant has been 
documented in various in vivo studies. Used frequently in the equine industry as a 
prophylactic treatment against Equine Respiratory Disease Complex (ERDC), P. acnes 
plays a role in activating the immune system through heightened macrophage function. 
While this activation is acknowledged, little is known about the specific pathway through 
which P. acnes act to bring about this activation. In an attempt to understand the 
mechanism of macrophage activation by P. acnes, studies were carried out using the 
macrophage cell line RAW 264. 7. Treatment of RAW 264. 7 cells with P. acnes in the 
presence of lipopolysaccharide (LPS) caused the activation of macrophages as observed 
by morphological changes. It also caused the induction of the inducible nitric oxide 
synthase (iNOS) in these cells. This induction of iNOS was dose-dependent and 
synergistic with LPS. 
INTRODUCTION 
Immunostimulation is a rapidly growing area in veterinary medicine. The United 
States Department of Agriculture has recently licensed numerous products for veterinary 
use that are directed toward nonspecific stimulation of the immune system. EqStim is 
one such product, manufactured by ImmunoVet, Inc. of Tampa, Florida (I). 
EqStim is a 0. 4 mg/mL nonviable Propionobacterium acnes suspended in 12. 5'/0 
ethanol in saline. Given intravenously, EqStim stimulates a rapid activation of the 
macrophages resulting in the production of a variety of cytokines (I). Macrophages are 
known to play a key role in the immune response. Use of P. acnes as an 
immunostimulant has been shown to influence the major components of the immune 
system: macrophage activation, subsequent cytokine production, and enhanced activity 
and proliferation of B cell and T cell lymphocytes (I). The nonspecific immune 
stimulation by P. acnes results in activation of macrophages and the production of 
cytokines by the macrophages and immune cascade that they initiate (I). 
Propionibacterium acnes. 
Propionibacterium acnes are common bacterial flora of the skin, typically found 
within the deeper recesses (2). Acne inflammation begins with non-inflamed 
microcomedones, which eventually rupture, releasing the microflora of the follicle, 
P. acnes is thought to be the main component of this microflora. Extensive research has 
been done on P. acnes, not only in relation to acne models, but also for its unusual ability 
to stimulate the reticuloendothelial system (RES) (3). The resistance of P. acnes cell 
wall to digestion, and subsequent persistence of phagocytized bacteria within the 
macrophages appears to be key in this ability (3, 4). This stimulation has been 
demonstrated by enhanced clearance of particles from the bloodstream, resistance to viral 
infection, and resistance to tumor growth (5, 6, 7). Furthermore, it has been shown that 
intact, whole killed organisms are required for macrophage activation (8), in contrast to 
isolated components of other immunomodulator such as LPS (9). The component of 
P. acnes that is responsible for the activation of macrophages must be present in the 
immune system in the structural arrangement that is found in the intact organism. 
Further, it has been described that removal of the active component or disruption of the 
organisms' structure results in the loss of its ability to activate macrophages (8). 
Recognition and phagocytosis of P. acnes by macrophages triggers a series of 
biochemical events which leads to macrophage activation. An inability to eAectively 
degrade this whole bacterium is potentially the cause of a persistent activation signal, 
hence prolonged macrophage activation (7). 
Macrophages. 
Macrophages have been found to play a key role in the early stages of wound 
healing (10). The importance of macrophage activation has been noted by many (11-15), 
resulting in a great number of studies undertaken in an attempt to stimulate macrophage 
activation, hence wound healing. Macrophage activation, as shown by Hunt er al (16), 
was seen to induce increased angiogenesis, fibroplasia, and collagen synthesis, important 
stages in the process of wound healing (15). Numerous immunomodulators have been 
studied for their abilities to activate macrophages. Such activation, leading to increased 
wound healing, would be of significant benefit to the medical community. 
Capable of repeated phagocytosis of foreign material, macrophages are 
responsible for the processing and presentation of foreign material for an immune 
response. Other functions include the release of cytokines, along with various other 
mediators that amplify an immune response, inflammation control, and the removal and 
repair of damaged tissues (12). 
Macrophages are round cells, with a single nucleus. They are strongly adherent to 
glass/plastic surfaces. This anchorage dependence, attachment to and some degree of 
spreading on, is required for cell culture proliferation (17). This spreading is 
accomplished by long cytoplasmic filaments which are extended out from the body of the 
cell. 
Normally found as "resting" macrophages, activation occurs upon exposure to 
inflammatory stimuli in inflamed tissues. Activated macrophages show heightened levels 
of phagocytic and secretory abilities, and are now known as "inflammatory" 
macrophages. Further, stimulation by bacterial products, such as P. acnes, results in 
"activated" macrophages (12). 
Macrophages that have been activated in such a fashion, usually become enlarged. 
They tend to show increased membrane activity, especially seen as increased pseudopod 
formation. Activated macrophages are also seen to move much more rapidly than their 
unstimulated counterparts, in response to chemotactic stimuli. Activation also seems to 
impart an enhanced ability to kill intracellular organisms and tumor cells (18). Together, 
the effects of activation allow macrophages a significantly increased effectiveness in the 
defense of the immune system (12). 
A key reason attributed to their increased effectiveness lies in the generation of 
reactive nitrogen metabolites. Activated macrophages produce large quantities of nitric 
oxide. Nitric oxide is regarded as the effector molecule responsible for the tumoricidal 
and microbicidal activity of activated macrophages. Typically, a synergistic combination 
is required for maximal induction of the enzyme NO synthase (iNOS), which converts 
arginine and oxygen into citrulline and NO. However, once iNOS synthesis has 
occurred, prolonged, high production of NO is possible (5, 9, 19). 
The many changes seen in activated macrophages allow for their increased 
microbicidal activity. Activated macrophages are thereby capable of a non-specific, cell- 
mediated immune response. Such non-specificity enables activated macrophages to 
phagocytose and destroy normally resistant organisms (12). 
The purpose of this research was to study in vitro the activation of macrophages 
by P. acnes using a macrophage cell line RAW 264. 7 . 
MATERIALS AND METHODS 
Reagents and cell culture. 
The mouse macrophage cell line RAW 264. 7 cells (Abelson leukemia virus 
transformed monocytic macrophage cell line)) was obtained from the American Type 
Culture Collection (Rockville, Maryland). Cells were cultured in Dulbecco's modified 
Eagle's medium (DMEM) (Gibco BRL, Grand Island), which was supplemented with 
high glucose, L-glutamine, 110 mg/L sodium pyruvate, 10'/o fetal bovine serum (FBS) 
(Gibco BRL, Grand Island), and I'i'0 (v/v) penicillin (10000 U/ml) / streptomycin (10000 
U/ml) (P/S) (Gibco BRL). All cell culture reagents were obtained from Life 
Technologies (Grand Island, NY). Propionibacterium Acnes, Immunostimulant (Serial ff 
670), consisting of 0. 4 mg/mL nonviable Propionibacterium acnes suspended in 12. 5'/0 
ethanol in saline, was obtained from ImmunoVet, Inc. (Tampa, Florida). Bacterial LPS 
(Escherichia cali serotype 0111:B4) was obtained from Sigma Chemical (St. Louis, MO), 
Macrophage activation. 
RAW 264. 7 cells (1X10 ) were seeded into 60-mm tissue culture dishes and 
incubated overnight at 37 C in 5'to CO& in air to allow for adherence. Cells were 
incubated with varying dilutions of Propioni bacterium acnes, Immunostimulant for 
4 hours. At the end of the incubation period, the stimulus was removed, and replaced 
either with fresh medium or 10 ng/ml LPS. After a further incubation period of 48 hours, 
the medium was removed for use in the nitric oxide measurement. Cells were then rinsed 
twice with IX PBS before being scraped off the plate in 250 pl of lysis buffer (10 mM 
Tris-Cl pH 7. 5), I'to SDS) that had been heated to 80 C prior to adding. Cell lysates 
were transferred to sterile eppendorf tubes using a 21. 5 gauge needle. They were further 
incubated at 80 C for five minutes and then cooled on ice before being stored at 4 C, 
Assay for NO synthesis. 
Synthesis of NO was determined by assay of culture supernatants for NO; a 
stable reaction product of NO with molecular oxygen. Briefly, 50 irl of culture 
supernatant was incubated with an equal amount of Greiss reagent [0. 55'0 sulfanilamide, 
0. 05'to N-(1-naphthyl)etheylenediamine dihydrochloride in 2. 5'/o HsPO4] in a 96-well 
tissue culture plate for ten minutes at room temperature. The amount of colored product 
was determined spectrophotometrically at 570 nm in an automated ELISA reader (MR 
600, Dynatech, Torrance, CA), The amount of nitrite was estimated, according to the 
standard curve generated using known concentrations of sodium nitrite. Results are 
presented as nmol NO/Itg protein/48 hours. 
Protein estimation. 
The BCA Protein Assay (Pierce, Rockford, IL) was used for the 
spectrophotometric determination of protein concentration. 
Cell staining. 
To determine the effects of P. acnes and LPS on macrophage morphology, RAW 
264. 7 cells were allowed to adhere in each chamber of two-chamber Lab-tek culture 
slides (Nunc, Naperville, CT). Adherent macrophages were then cultured for 4 hours 
with varied dilutions of P. acnes. Following this incubation, medium was removed and 
replaced either with fresh medium alone or 10 ng/ml LPS. 
Western blot. 
Cell monolayers were washed with ice-cold PBS and lysed in buffer containing 
10 mM Tris, pH 7, 4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0. 2 mM sodium 
phenylmethylsulfonyl fluoride. SDS-PAGE (10/o) was conducted under denaturing, 
reducing conditions according to Laemmli (22). Proteins were transferred onto 0. 2-pm- 
pore-sized polyvinylidene difluoride membrane (Immobilon-P; Millipore, Bedford, MA) 
using 15'lo methanol, 25 mM Tris, and 192 mM glycine, pH 8 3 The membrane was 
blocked for 1 hour at room temperature with I'io bovine serum albumin in Tris-buffered 
saline (25 mM Tris, pH 7. 5, 150 mM NaCl, 0. 1'%%d Tween 20) and then incubated with 
mouse anti-mac-NOS monoclonal antibody (1/500 dilution; Transduction Labs) for 
1 hour at room temperature. The membrane was washed with Tris-buffered saline and 
then subsequently incubated for 1 hour with anti-mouse IgG conjugated to alkaline 
phoshatase (Sigma Chemical). After washing, the membrane was equilibrated in alkaline 
phosphatase buffer (100 mM Tris, pH 9. 5, 100 mM NaC1, 5 mM MgClz) and developed 
in a solution of 167. 5 lrg/ml nitro blue tetrazolium and 167. 5 ttg/ml 5-bromo-4-chloro-3- 
indoyl phosphate in alkaline phosphatase buffer. 
RESULTS 
Effects of P. acnes and LPS on macrophage morphology. 
When cultured in medium alone, normal RAW cells tend to be round in shape. 
and have small, lobular nuclei. No spreading is evident (Figure IA). RAW cells exposed 
to P. acnes alone appeared to have moderate cytoplasmic spreading and slight 
vacuolation (Figure 1B). RAW cells exposed to LPS appear to have slight spreading and 
vacuolation (Figure IC). In contrast, RAW cells exposed to both LPS and P. acnes were 
greatly enlarged. They appear highly vacuolated with increased cytoplasmic spreading 
(Figure ID). Per field, activation (Figure ID) is proportionately elevated in comparison 
to the figures previously described (Figures IA, IB, IC). 
The effects P. nenes and LPS on nitric oxide production. 
As shown in Figure 2, RAW cells release a limited amount of nitric oxide in 
response to medium alone. When exposed to P. acnes, the cells exhibit a dose dependent 
increase in nitric oxide production. RAW cells exposed to LPS alone show a 
significantly increased production of nitric oxide. However, an even more significant 
increase is shown in RAW cells exposed to both LPS and P. acnes, again exhibiting a P. 
acnes dose dependency. P. acnes (I:1000) and (I:10, 000) dilutions showed the greatest 
increase in nitric oxide production over LPS alone. This suggests that more highly 
activated macrophages were obtained from RAW cells treated with LPS and P. acnes in 
combination. 
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The effects of P. acnes and LPS on total protein content. 
As shown in Figure 3, total protein content of RAW cells in medium alone, as 
well as those treated with varying doses of P. acnes, exhibit similar concentrations. A 
significant increase in protein concentration is seen in control cells treated with LPS 
alone. However, in those RAW cells treated both with P, acnes and LPS, an even larger 
increase in protein concentration can be seen in 1:10 and I:100 dosages. The 
P. acnes/LPS combination protein concentrations are then reduced in 1:1000 and 
I:10, 000 P. acnes dosages. 
Western blot analysis of iNOS. 
P. acnes in the presence of LPS induced the expression the iNOS protein. 
Treatment of RAW cells with P. acnes in the presence of LPS for a period of 48 hours 
induced the expression of the iNOS protein (Figure 5). This expression was not dose 
dependent. However, treatment of cells with LPS alone or P. acnes (I;10) alone, also 
induced expression to an equal extent. Low levels of iNOS protein were observed in 
cells treated with media alone, as well as in those treated with higher dilutions of P. 
acnes. 
The effects of LPS and Interferon — y on RAW cells. 
In preparation for the previous experimentation, the RAW cell activation model 
using LPS and IFN-I developed by Nathan, et. al. (9, 19), was reproduced with similar 
results, as seen in Figure 4. The reproduction of these results allowed for the basic 
understanding of techniques involved. Furthermore, this model provided an excellent 
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basis upon which to build the P. acnes inodel, due to its similar nature and proficiency in 
describing the pathway of LPS activation. These results proved useful for comparison to 
those of P. acnes experimentation. 
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DISCUSSION 
Used extensively in equine medicine, EqStim has been shown to be effective in 
the treatment of Equine Respiratory Disease Complex (ERDC) (20). Administered 
prophylactically, a significant decrease in the incidence of stress-induced ERDC was 
shown in horses during and following transportation. Prophylactic use of 
immunostimulants has been shown to be effective in enhancing nonspecific resistance to 
viral infection and tumor metastasis (7). Research by A. Nevsted has indicated that 
horses are at increased risk of respiratory infections during shipping, due to stress placed 
on the animal. This stress leads to the "down-regulation" of the animal's immune system 
and makes them more susceptible to infections. By activating the immune response (i. e. 
macrophage activity) prior to pathogen exposure, there is a potential to enhance a horse' s 
ability to withstand such a challenge (20). Further studies by Nevsted have indicated that 
protection against illness is based upon the short term (9-14 days) stimulation of cell 
mediated immune response. 
Economically, respiratory disease in horses can prove extremely costly to owners 
in both down time and in antibiotic treatment. The use of products such as EqStim can 
prove extremely useful and cost effective on a prophylactic basis. The cost of this 
immunostimulant is minimal in comparison to the costs associated with treatment of a 
sick horse. In addition, P. acnes used in addition to conventional antibiotic therapy has 
been shown to accelerate the recovery rates in acute and chronic ERDC cases by as much 
as 60'/0. The multiple-dose regime of P. acnes also allows for a greater flexibiLity in 
treatment of the patient, according to individual clinical improvement (21). 
13 
The symptoms of ERDC seen commonly in equine practices include nasal 
discharge and cough syndrome. Antibiotics are normally effective against bacterial 
pathogens, however, if the horse is immunodeficient, these symptoms will recur even 
following a prolonged antibiotic treatment regime. In addition, antibiotics prove 
ineffective against a viral component involved in ERDC infections. Many veterinarians 
have come to rely on EqStim for the treatment of horses exhibiting symptoms such as 
these. Administration of a dose of EqStim during the initial visit, together with antibiotic 
therapy has been shown to shorten the recovery time as compared to using antibiotics 
alone. In summary, "'Immune stimulation, through stimulation of macrophage activities, 
provides a rational basis for treatment of any animal disease where the immune system 
gives evidence of sub-optimal function'" (21). 
P. acnes products have a broad range of usage, not limited merely to ERDC. Off 
label studies include the treatment of osteomyelitis, chronic endometritis, and wounds in 
horses. The treatment of tumors, feline leukemia cats, canine parvo infection, 
demodectic mange, and canine/feline respiratory disease has also benefited from the use 
of P. acnes immunostimulation (1). With such profound results shown in in vivo studies, 
the experimentation previously described was undertaken in order to better understand 
the pathways of macrophage activation by the EqStim immunostimulant, P. acnes. 
While there was a significant amount of literature pertaining to the activation of 
macrophages, the vast majority was carried out using in vivo studies. Additionally, very 
little correlation could be found among the publications. It appeared that each had 
followed a separate idea, none building upon the findings of another as is evident in LPS 
studies of a similar nature. Therefore, it was difficult to follow the progress made in 
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determining the signal transduction pathways involved in the activation of macrophages 
by P. acnes. 
The signal transduction pathway involved in the activation of macrophages by 
LPS is extremely well described, having been determined in a methodical and 
progressive nature (9). This model of macrophage activation by LPS was used as a basis 
for performing the experiments with P. acnes. 
P. acnes in the presence of LPS caused the activation of macrophages as observed 
by the morphological changes. Immunologically activated macrophages produce NO, the 
reactive free radical that mediates the bactericidal and tumoricidal activities of 
macrophages. P. acnes in the presence of LPS also caused an increase in the production 
of nitric oxide in these cells. This increase in NO production was dose dependent and 
synergistic with LPS. However unlike the LPS stimulation where there was an increase in 
NO production with increasing concentrations of LPS, higher concentrations of P. acnes 
caused a decrease in NO production. Moreover there was no dose dependent increase in 
the expression of the iNOS protein. These results indicate that although both LPS and P, 
acnes cause the activation of macrophages, they might be doing this by two different 
pathways. Induction of iNOS by LPS involves NFxB, an interferon response element 
(24). It would be interesting to see if these transcription factors are also involved in the 
action of P. acnes. 
EqStim is used rather sparingly in horses, recommended dosages being 1 ml per 
250 lbs. of body weight in mature horses (21). Producing only a mild rise in temperature, 
tremors, and inappetence up to 24 hours post administration, this product is generally 
regarded as safe (1). The concentrations used in these experiments were proportionately 
greater than would normally be found in the body system. However it is difficult to 
compare results from this study on a transformed cell line with those from in vivo studies. 
The next logical step to be taken would be to apply this P. acnes model to mouse 
macrophages in vitro, and then possibly to take those findings to an in vivo mouse study. 
By progressively building upon these results, it is hoped that the P. acnes 
activation pathway may one day be developed as fully as that of LPS. Such knowledge 
could prove extremely beneficial not only in furthering the treatment of animal 
infections, but in the realm of human medicine, as well. The capacity to therapeutically 
manipulate macrophage function holds great potential for the medical community, at 
large. 
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Figure 1. Macrophage morphological changes in response to Propionibacreriurn nenes. RAW cells 
were cultured on two-chamber Lab-tek culture slides in medium alone ( A ), 10 ng I ml LPS ( B ), 1:10 P. 
certes ( C ), and the combination ( D ) for 24 hours. 
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FIGURE 5. Dose dependent analysis of induction of iNOS protein by 
Propionibaclerium acnes and Lipopolysaccharide (LPS). RAW 264. 7 cells were 
incubated in varying dilutions of P. acnes in the presence or absence of LPS (10 ng/ml) 
for 24 hours. Total cell lysates were subjected to SDS-PAGE (10%), blotted onto a 
polyvinylidene difluoride membrane, and probed with anti-mac-NOS antibody. Lane 1 
represents the migration of the molecular weight markers, lane 2 is the positive control 
for iNOS (Transduction Labs, Inc. ), lanes 3-6 represents LPS (10 ng/ml) + P. acnes 
(1. 10, 000, I:1, 000, 1:100, I:10), lane 7 represents LPS alone, lanes tt-I I represents 
P. acnes (1:10, 000, 1. 1, 000, 1:100, 1:10), and lane 12 represents treatment with medium 
alone. The iNOS band is at 130 kDa. 
